SNSA Congress Committee 2022
Patrick Lekgwara – Chairman, SNSA 2022 Congress
John Ouma – President, SNSA
Anthony Figaji – SNSA President Elect
Llewellyn Padayachy – Scientific Chair
Coceka Mfundisi – SNSA Treasurer
Rohen Harrichandparsad –Exhibition Chair
Scientific Review Committee to be confirmed
Aaron Cohen-Gadol (Cohen)
Dr Aaron Cohen-Gadol (Cohen) performed his undergraduate and medical school trainings at the University of California at San Diego and University of Southern California, respectively. He then completed his residency training at Mayo Clinic in Rochester, Minnesota. He also completed fellowship training in two subspecialties: epilepsy surgery (Yale University) and skull base/cerebrovascular surgery (University of Arkansas). Dr Cohen has a Masters Degree in Clinical Research from Mayo Graduate School and an MBA from Kelley School of Business. His areas of interest include surgical treatment of complex intracranial tumours and vascular lesions. He is a professor at Indiana University Department of Neurosurgery. He is the director of neurosurgical oncology and its fellowship. He is the founder and president of The Neurosurgical Atlas (http://www.neurosurgicalatlas.com), a multimedia resource for neurosurgical techniques. His clinical research interests include neurosurgical operative anatomy, innovative operative approaches to deep lesions, and intraoperative fluorescence/mass spectroscopy. His basic science research is focussed on novel drug therapies for glioblastoma. He has published more than 510 publications on the aforementioned topics. Dr Cohen is a member of the American Academy of Neurological Surgery and World Academy of Neurological Surgery. He is also the Associate Editor-in-Chief of the journal Neurosurgical Focus.
Dr Aliasgar Moiyadi is Professor and presently heads the neurosurgical oncology services at the Tata Memorial Centre (TMC), Mumbai, India. He completed his neurosurgical training from the National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, a premier neuroscience training institute in India. He was instrumental in establishing the Neurosurgical Oncology services at TMC, one of the few neurosurgical departments in India catering to neuro-oncology exclusively. His areas of interest include novel strategies for improving visualisation and resection of gliomas, particularly navigated ultrasound and optical imaging (which he has pioneered in the country), intraoperative brain mapping including awake surgeries, surgery for eloquent tumours and insular gliomas, minimally invasive neurosurgery, skull base surgery, and biology of malignant brain tumours. Dr Moiyadi has more than 150 peer-reviewed publications and is on the editorial board of many neurosurgical journals, in addition to being the tumour section Editor for World Neurosurgery, one of the leading neurosurgical journals. He is also involved in many clinical trials and translational research projects. He has served as a member of the World Federation of Neurosurgical Societies (WFNS) Technology Committee and the Executive Committee of the Indian Society of Neuro-oncology. He is passionate about teaching and training, especially in the field of neurosurgical oncology. He has a special interest in, and has been at the forefront of educational and training efforts in, the field of intraoperative ultrasound and brain mapping, conducting numerous symposia and hands-on workshops in India and across the world.
Dr Claude Hemphill is Professor of Neurology and Neurological Surgery at the University of California, San Francisco and Chief of Neurology and Director of Neurocritical Care at Zuckerberg San Francisco General Hospital. His research focusses on advanced neuromonitoring, informatics, and management of intracerebral haemorrhage. He is a founding director and Past-President of the Neurocritical Care Society and is a member of the editorial board of Neurocritical Care. His work has been previously funded by the National Institutes of Health through a K23 Career Development Award to study intracerebral haemorrhage and as PI of the San Francisco hub of the Neurological Emergencies Treatment Trials Network to conduct clinical trials for various neuro-emergencies such as traumatic brain injury, status epilepticus, and stroke. He is the current co-chair of the Neurocritical Care Research Network and of the Curing Coma Campaign of the Neurocritical Care Society. He also served as chair of the writing groups for the 2015 American Heart Association/American Stroke Association Guidelines for the Management of Spontaneous Intracerebral Hemorrhage and the 2018 Clinical Performance Measures for Adults Hospitalized with Intracerebral Hemorrhage.
Abstract submission opens
WEDNESDAY, 13 APRIL 2022
Abstract submission deadline
WEDNESDAY, 1 JUNE 2022
Notification to authors
FRIDAY, 8 JULY 2022
Online registration opens
WEDNESDAY, 1 JUNE 2022